GeneBioTech Co. ,Ltd (KOSDAQ:086060)

GeneBioTech Co. ,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 17, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42,106	34,528	28,329	37,542	34,356	45,119
Market Cap Growth	54.50%	21.88%	-24.54%	9.27%	-23.86%	-8.87%
Enterprise Value	32,166	26,516	19,776	30,940	31,105	35,590
Last Close Price	4890.00	4010.00	3249.43	4306.24	3940.80	5175.39
PE Ratio	11.11	9.11	9.89	14.49	22.55	-
PS Ratio	0.46	0.38	0.34	0.47	0.42	0.72
PB Ratio	0.77	0.63	0.56	0.78	0.75	1.03
P/TBV Ratio	0.77	0.64	0.56	0.79	0.77	1.05
P/FCF Ratio	10.92	8.95	-	5.49	-	-
P/OCF Ratio	5.53	4.54	-	5.10	-	-
EV/Sales Ratio	0.35	0.29	0.24	0.39	0.38	0.57
EV/EBITDA Ratio	5.98	4.93	3.79	5.83	10.94	44.98
EV/EBIT Ratio	8.05	6.64	5.15	7.79	19.98	-
EV/FCF Ratio	8.34	6.88	-	4.52	-	-
Debt / Equity Ratio	0.27	0.27	0.31	0.26	0.28	0.23
Debt / EBITDA Ratio	2.78	2.78	3.05	2.35	4.58	13.02
Debt / FCF Ratio	3.88	3.88	-	1.83	-	-
Net Debt / Equity Ratio	-0.18	-0.18	-0.15	-0.20	-0.07	-0.17
Net Debt / EBITDA Ratio	-1.85	-1.85	-1.44	-1.79	-1.08	-9.46
Net Debt / FCF Ratio	-2.58	-2.58	4.81	-1.39	0.63	1.29
Asset Turnover	1.23	1.23	1.20	1.22	1.33	1.03
Inventory Turnover	4.92	4.92	4.37	4.35	4.97	4.59
Quick Ratio	2.39	2.39	2.02	2.33	1.91	1.99
Current Ratio	3.48	3.48	3.04	3.40	2.91	2.98
Return on Equity (ROE)	7.15%	7.15%	5.77%	5.51%	3.40%	-1.03%
Return on Assets (ROA)	3.38%	3.38%	3.48%	3.82%	1.56%	-0.46%
Return on Invested Capital (ROIC)	7.53%	7.75%	7.65%	7.49%	3.30%	-1.39%
Return on Capital Employed (ROCE)	6.70%	6.70%	7.20%	7.70%	3.20%	-1.00%
Earnings Yield	9.00%	10.97%	10.11%	6.90%	4.43%	-1.07%
FCF Yield	9.16%	11.17%	-5.52%	18.21%	-14.07%	-12.89%
Buyback Yield / Dilution	-0.08%	-0.08%	0.07%	-	-	-
Total Shareholder Return	0.95%	-0.08%	0.07%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.